Active Ingredient History
Hydrocortisone valerate is a synthetic glucocorticoid corticosteroid and a corticosteroid ester. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Adrenal Hyperplasia, Congenital (approved 1952)
Arthritis, Rheumatoid (approved 1952)
Leukemia (approved 1952)
Adrenal Cortex Hormones (Phase 2)
Adrenal Gland Diseases (Phase 1/Phase 2)
Adrenal Gland Neoplasms (Phase 2)
Adrenal Hyperplasia, Congenital (Phase 4)
Adrenal Insufficiency (Phase 4)
Adrenocortical Hyperfunction (Phase 1/Phase 2)
Adult (Phase 2/Phase 3)
Alcohol Drinking (Early Phase 1)
Allografts (Phase 3)
Atrial Fibrillation (Phase 2/Phase 3)
Blood Pressure (Phase 1)
Burkitt Lymphoma (Phase 2)
Cigarette Smoking (Phase 1)
Cocaine-Related Disorders (Phase 1)
Colitis (Phase 2)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Phase 1/Phase 2)
COVID-19 (Phase 3)
Critical Illness (Phase 2/Phase 3)
Cyclosteroids (Phase 3)
Deficiency Diseases (Phase 4)
Depression (Phase 4)
Disorders of Sex Development (Phase 1/Phase 2)
Down Syndrome (Phase 2)
Drinking Behavior (Early Phase 1)
Drugs, Investigational (Phase 4)
Dry Eye Syndromes (Phase 4)
Eczema (Phase 4)
Fasting (Phase 4)
Fibrosis (Phase 4)
Genetic Diseases, Inborn (Phase 1/Phase 2)
Granulomatous Mastitis (Phase 4)
Healthy Volunteers (Phase 4)
Heart Rate (Early Phase 1)
Hemorrhoids (Phase 3)
HIV (Early Phase 1)
Hydrocortisone (Phase 4)
Hyperplasia (Phase 1/Phase 2)
Hypoxia (Phase 3)
Influenza, Human (Phase 1/Phase 2)
Intertrigo (Phase 4)
Kidney Diseases (Phase 3)
Leukemia (Phase 1)
Leukemia, Lymphoid (Phase 1)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, T-Cell (Phase 1)
Lipomatosis, Multiple Symmetrical (Phase 3)
Lymphoma (Phase 2)
Lymphoma, T-Cell (Phase 1)
Meibomian Gland Dysfunction (Phase 4)
Memory, Episodic (Early Phase 1)
Memory, Long-Term (Early Phase 1)
Metabolic Diseases (Phase 3)
Myelodysplastic Syndromes (Phase 1)
Neoplasms (Phase 2)
Neuroblastoma (Phase 1/Phase 2)
Opioid-Related Disorders (Phase 2)
Osteoarthritis, Knee (Phase 4)
Pain (Phase 4)
Pancreatitis (Phase 2)
Polymyalgia Rheumatica (Phase 2)
Post-Cardiac Arrest Syndrome (Phase 3)
Post-Dural Puncture Headache (Phase 4)
Proctitis (Phase 3)
Psoriasis (Phase 1)
Psychological Distress (Phase 2)
Sepsis (Phase 4)
Severe Acute Respiratory Syndrome (Phase 2)
Shock, Cardiogenic (Phase 3)
Shock, Septic (Phase 4)
Sleep Disorders, Intrinsic (Phase 1)
Steroid Metabolism, Inborn Errors (Phase 1/Phase 2)
Stress Disorders, Post-Traumatic (Phase 2)
Stress Disorders, Traumatic, Acute (Phase 2)
Tacrolimus (Phase 1/Phase 2)
Thoracic Surgery (Phase 3)
Traumatology (Phase 2)
Urogenital Abnormalities (Phase 1/Phase 2)
Vasoconstriction (Phase 1)
Vasoplegia (Phase 3)
Vitiligo (Phase 1/Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
